SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway

The efficacy of corticosteroids and its use for the treatment of SARS-CoV-2 infections is controversial. In this study, using data sets of SARS-CoV-2 infected lung tissues and nasopharyngeal swabs, as well as in vitro experiments, we show that SARS-CoV-2 infection significantly downregulates DUSP1 e...

Descripción completa

Detalles Bibliográficos
Autores principales: Saheb Sharif-Askari, Fatemeh, Saheb Sharif-Askari, Narjes, Goel, Swati, Hafezi, Shirin, Assiri, Rasha, Al-Muhsen, Saleh, Hamid, Qutayba, Halwani, Rabih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295491/
https://www.ncbi.nlm.nih.gov/pubmed/34303662
http://dx.doi.org/10.1016/j.ejphar.2021.174374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295491/
https://www.ncbi.nlm.nih.gov/pubmed/34303662
http://dx.doi.org/10.1016/j.ejphar.2021.174374

Ejemplares similares